爱美客：收购韩国REGEN Biotech, Inc.公司控股权交割完成

Core Viewpoint - The company has successfully completed the acquisition of 85% of REGEN Biotech, Inc. for $190 million, enhancing its international market presence and future profitability [1] Group 1 - The acquisition was executed through the company's wholly-owned subsidiary, Aimeike Hong Kong, in collaboration with Aisheng Shourui (HK) Limited [1] - The transaction has been fully settled, resulting in the company obtaining a 59.5% stake in REGEN Biotech, Inc. [1] - This strategic move is expected to strengthen the company's core competitiveness and expand its international market reach [1]